Goldberg Scott L. 4
4 · CNO Financial Group, Inc. · Filed Mar 23, 2026
Research Summary
AI-generated summary of this filing
CNO Financial (CNO) President Scott Goldberg Exercises Options, Sells Shares
What Happened
Scott L. Goldberg, President of the Consumer Division at CNO Financial, exercised a total of 22,120 stock options (11,060 on 2026-03-19 and 11,060 on 2026-03-20) at an exercise price of $21.06 per share (total cash paid $465,848). He then sold the 22,120 shares in open-market transactions: 11,060 shares on 2026-03-19 at a weighted average price of $39.97 (gross proceeds $442,078) and 11,060 shares on 2026-03-20 at a weighted average price of $39.54 (gross proceeds $437,346). The filing also reports the corresponding derivative instruments as disposed at $0, which reflects the options being exercised.
Key Details
- Transaction dates: 2026-03-19 and 2026-03-20. Filing date: 2026-03-23 (filing is within typical SEC timing for these transactions).
- Options exercised: 22,120 shares total at $21.06 per share (total exercise cost shown as $232,924 on each date; $465,848 total).
- Shares sold: 22,120 shares total; gross sale proceeds ~$442,078 (3/19) + ~$437,346 (3/20) = ~$879,424.
- Sales executed pursuant to a Rule 10b5-1 trading plan adopted Nov 6, 2025 (footnote F1).
- Weighted average sale prices reported; sale price ranges provided in footnotes (F2 and F3); reporting person will provide per-price details on request.
- Vesting note: the underlying options vested in two tranches (one-half in Feb 2019 and one-half in Feb 2020) (footnote F4).
- Shares owned after the transactions are not specified in the provided excerpt.
Context
This was an exercise of vested options followed by immediate or near-immediate open-market sales (commonly a “cashless” outcome), executed under a pre-established 10b5-1 plan — a routine mechanism executives use to sell shares while reducing questions about trading on inside information. The filing is factual and does not indicate the insider’s motives; purchases generally carry more informational weight than routine option exercises followed by sales.
Insider Transaction Report
- Exercise/Conversion
Common Stock
2026-03-19$21.06/sh+11,060$232,924→ 225,584 total - Sale
Common Stock
[F1][F2]2026-03-19$39.97/sh−11,060$442,078→ 214,524 total - Exercise/Conversion
Common Stock
2026-03-20$21.06/sh+11,060$232,924→ 225,584 total - Sale
Common Stock
[F1][F3]2026-03-20$39.54/sh−11,060$437,346→ 214,524 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
[F4]2026-03-19−11,060→ 11,060 totalExercise: $21.06Exp: 2027-02-23→ Common Stock (22,120 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
[F4]2026-03-20−11,060→ 0 totalExercise: $21.06Exp: 2027-02-23→ Common Stock (11,060 underlying)
Footnotes (4)
- [F1]Shares sold pursuant to a Rule 10b5-1 trading plan adopted on November 6, 2025.
- [F2]Reflects the weighted average sale price. Shares were sold at prices ranging from $39.75 per share to $40.295 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.
- [F3]Reflects the weighted average sale price. Shares were sold at prices ranging from $39.28 per share to $39.96 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.
- [F4]One-half of the stock options vested and became exercisable on February 23, 2019, and one-half vested and became exercisable on February 23, 2020.